60 Degrees Pharmaceuticals Secures Agreement for Exercise of Warrants Covering 584,492 Shares

• 60 Degrees Pharmaceuticals entered agreements November 5, 2026, for cash exercise of existing warrants covering 584,492 shares at a reduced $0.90 apiece.
• Expected gross proceeds total $526,042.80, with closing anticipated November 9, 2026; net proceeds will fund working capital and general corporate purposes.
• Holders will receive new unregistered warrants covering 1,168,984 shares, representing 200% of shares issued through the existing warrant exercises.
• The new warrants carry a $0.90 exercise price; exercise requires stockholder approval of the underlying share issuance.
• Expiration follows the later of stockholder approval or resale registration effectiveness: five years for 560,912 shares; 24 months for 608,072 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-116620), on November 06, 2026, and is solely responsible for the information contained therein.